Navigation Links
Egenix, Inc. Appoints Matthew Fury, M.D., Ph.D. to its Scientific Advisory Committee
Date:10/23/2013

MILLBROOK, N.Y., Oct. 23, 2013 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Matthew Fury, M.D., Ph.D. to its Scientific Advisory Committee.

Dr. Fury is a Medical Oncologist in The Department of Medicine at Memorial Sloan-Kettering. Since 2006 Dr. Fury has been conducting clinical research focused on mTOR/eIF4E inhibitors for Human Papilloma related head and neck cancers. He will now be participating in a collaboration with Egenix in the development of a drug for HPV.

We at Egenix are delighted to have Dr. Fury aboard.

Egenix is a privately held, New York-based biotechnology company focused on the development of innovative cancer therapeutics. The company's therapeutic platform technology consists of small molecule drugs applicable for the treatment and prevention of a broad spectrum of cancers, autism, and Alzheimer's. Our lead drug candidates inhibit the "translation initiation factor" eIF4E, specifically blocking production of multiple cancer promoting proteins and promoting apoptosis (programmed cell death) and upregulation of tumor suppressor genes. The company licensed this technology from Harvard Medical School in 2007. eIF4E is an attractive cancer therapeutic target because every function necessary for cancer growth and metastasis is influenced or mediated be a gene product that is regulated by this translation initiation factor. Data from human cancer xenograft studies using two of our lead compounds tested against breast cancer and melanoma demonstrated 100% tumor inhibition and 20% to 30% tumor reduction. For more information visit www.egenixinc.com.


'/>"/>
SOURCE Egenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Egenix, Inc. Announces New Director, John Reid
2. Egenix, Inc. Announces New Director
3. Metamark Appoints Cornelius J. Merlini Chief Commercial Officer
4. ACTUS Appoints New Members to Its Management Team
5. Immune Design Appoints Stephen R. Brady Chief Business Officer
6. DiaVacs, Inc. Appoints Orville Kolterman, M.D. As Chief Medical Officer
7. Sanomedics International Holdings, Inc. appoints new Chairman of the Board and installs new Director of Business Development.
8. Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer
9. Cold Spring Harbor Laboratory Appoints Teri F. Willey to Accelerate Commercialization Efforts
10. Senn Chemicals Appoints New Chief Executive Officer
11. Novelda Appoints Alf-Egil Bogen as Chief Executive Officer to Lead the Company to the Next Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... and READING, England , ... Indegene ( http://www.indegene.com ), ein führender Anbieter ... die Life-Science-Branche, Pharmaunternehmen und Gesundheitsorganisationen, und TranScrip ... von innovativen wissenschaftlichen Support-Services für den gesamten ... IntraScience heute den Ausbau ihrer bestehenden Allianz ...
(Date:5/26/2016)... 26, 2016 Despite the volatility that ... this space. Today,s pre-market research on ActiveWallSt.com directs the investor ... (NASDAQ: RDUS ), Cerus Corp. (NASDAQ: ... and Five Prime Therapeutics Inc. (NASDAQ: FPRX ). ... http://www.activewallst.com/ On Wednesday, shares ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... of a Thai delegation at BIO 2016 in San Francisco. Located at booth ... will be available to answer questions and discuss the Thai biotechnology and life ...
(Date:5/25/2016)... ... 25, 2016 , ... WEDI, the nation’s leading authority on the use of ... Stellar has been named by the WEDI Board of Directors as WEDI’s president and ... leader with more than 35 years of experience in healthcare, association management and organizational ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):